NN
NNOX.US Nano X Imaging Ltd
- Market cap
- USD 25.4M
- P/E
- -
- P/B
- 0.35x
- ROE
- -192.5%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is NNOX.US undervalued?
Graham numberThe Graham number of Nano X Imaging Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Nano X Imaging Ltd fundamental analysis
No fundamental analysis for Nano X Imaging Ltd yet.
Nano X Imaging Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Nano X Imaging Ltd
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical …
Full company profileNano X Imaging Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Nano X Imaging Ltd annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 0.00 | 0.00 | 0.00 | 1.30M | 8.58M | 9.91M | 11.3M | 13.0M | 16.9M |
| Gross Profit | -35.0K | -53.0K | -208K | -1.51M | -6.88M | -6.59M | -10.6M | -12.8M | -92.7M |
| Operating Income | -1.90M | -22.6M | -43.9M | -61.6M | -110M | -62.6M | -56.7M | -60.7M | -141M |
| EBITDA | -1.87M | -22.5M | -43.7M | -59.3M | -75.7M | -47.7M | -45.0M | -49.0M | -129M |
| Net Income | -1.91M | -22.6M | -43.5M | -61.8M | -105M | -60.8M | -53.5M | -75.0M | -140M |
| EPS | -0.06 | -0.49 | -1.22 | -1.28 | -2.01 | -1.08 | -0.91 | -1.16 | -1.99 |
| Balance Sheet | |||||||||
| Total Assets | 1.86M | 11.9M | 236M | 363M | 254M | 219M | 210M | 162M | 91.2M |
| Total Liabilities | 8.24M | 20.6M | 5.40M | 71.0M | 37.3M | 23.1M | 20.9M | 22.4M | 18.7M |
| Shareholders' Equity | -6.38M | -8.78M | 231M | 292M | 217M | 196M | 189M | 140M | 72.5M |
| Cash & Short-term Investments | 5.00K | 8.07M | 213M | 88.7M | 77.6M | 82.4M | 73.2M | 59.6M | 31.0M |
| Total Debt | - | 526K | 1.44M | 5.77M | 4.62M | 8.40M | 7.45M | 7.85M | 7.73M |
| Cash Flow | |||||||||
| Operating Cash Flow | -3.67M | -5.52M | -21.5M | -38.1M | -43.4M | -44.8M | -36.6M | -40.8M | -51.1M |
| Capital Expenditure | 73.0K | 125K | 13.9M | 23.2M | 7.17M | 3.30M | 2.77M | 4.21M | 5.52M |
| Free Cash Flow | -3.74M | -5.65M | -35.4M | -61.2M | -50.6M | -48.1M | -39.4M | -45.0M | -56.6M |
| Ratios | |||||||||
| ROE | - | - | -18.9% | -21.2% | -48.6% | -31.1% | -28.3% | -53.7% | -192.5% |
| ROA | -102.9% | -190.0% | -18.4% | -17.0% | -41.4% | -27.8% | -25.5% | -46.3% | -153.0% |
| Net Profit Margin | - | - | - | -4,739.1% | -1,226.9% | -613.6% | -474.3% | -576.1% | -823.8% |
| Debt to Equity | - | - | 0.01x | 0.02x | 0.02x | 0.04x | 0.04x | 0.06x | 0.11x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Nano X Imaging Ltd dividends
Nano X Imaging Ltd has not paid dividends in the last 8 fiscal years.
Who owns Nano X Imaging Ltd
- Insiders 9.49%
- Institutions 8.23%
- Public & others 82.28%
- Shares outstanding 78.7M
- Free float 63.8M
Top funds holding NNOX.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| iShares Micro-Cap ETF | 217K | 0.28% | 0.00% | Oct 2026 |
| 1290 VT Micro Cap K | 16.2K | 0.02% | 0.00% | Sep 2026 |
| Dux Umbrella Trimming USA Technology FI | 16.0K | 0.02% | 0.00% | Apr 2026 |
| Gestión Boutique VI Gestivalue Cap A FI | 10.0K | 0.01% | 0.00% | Oct 2026 |
| Goldman Sachs Absolute Ret Trckr Instl | 94.00 | 0.00% | -1.05% | Jun 2026 |
| AXAWF Global Dynamic Allocation I CapUSD | 14.00 | 0.00% | 0.00% | Feb 2026 |
Top institutions holding NNOX.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| UBS Group AG | 1.48M | 1.88% | +9.54% | Jun 2026 |
| ARK Investment Management LLC | 807K | 1.02% | +10.00% | Jun 2026 |
| Marshall Wace Asset Management Ltd | 778K | 0.99% | 0.00% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 655K | 0.83% | +37.46% | Jun 2026 |
| BlackRock Inc | 596K | 0.76% | -84.39% | Jun 2026 |
| AQR Capital Management LLC | 561K | 0.71% | +13.32% | Jun 2026 |
| Bank of America Corp | 457K | 0.58% | -5.69% | Jun 2026 |
| The Goldman Sachs Group Inc | 349K | 0.44% | -8.01% | Jun 2026 |
| HRT FINANCIAL LLC | 330K | 0.42% | 0.00% | Jun 2026 |
| Susquehanna International Group, LLP | 325K | 0.41% | +228.07% | Jun 2026 |
| Renaissance Technologies Corp | 316K | 0.40% | 0.00% | Sep 2026 |
| Jain Global LLC | 304K | 0.39% | 0.00% | Jun 2026 |
| State Street Corp | 281K | 0.36% | -76.95% | Jun 2026 |
| BNP Paribas Arbitrage, SA | 272K | 0.34% | +516.88% | Jun 2026 |
| Royal Bank of Canada | 246K | 0.31% | +26.81% | Jun 2026 |
| Point72 Asset Management, L.P. | 202K | 0.26% | 0.00% | Jun 2026 |
| Schonfeld Strategic Advisors LLC | 147K | 0.19% | +5.95% | Jun 2026 |
| Barclays PLC | 147K | 0.19% | +225.28% | Jun 2026 |
| IEQ CAPITAL, LLC | 99.6K | 0.13% | +31.22% | Jun 2026 |
| Tempus Wealth Planning, LLC | 99.5K | 0.13% | -1.09% | Jun 2026 |
Nano X Imaging Ltd company profile
- Company name
- Nano X Imaging Ltd
- Ticker
- NNOX.US
- ISIN
- IL0011681371
- Exchange
- USA Stocks
- Listed since
- Aug 21, 2020
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 197
- Fiscal year end
- December
- Address
- 94 Shlomo Shmeltzer Road, Petah Tikva, Israel, 4970602
- Phone
- 972 3 373 59202
- Website
- nanox.vision
About Nano X Imaging Ltd
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data of existing computed tomography scans; and Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. In addition, the company provides Real+ Osteoporosis Care Management Platform, a osteoporosis care management software platform; AI-Based Aortic Valve Calcification Measurement, an artificial intelligence"based solution; AI-Based Body Composition Measurement, an artificial intelligence"based body composition analysis capability; and Nanox Health IT, a healthcare information technology services provider that serves hospitals and other healthcare organizations. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Petah Tikva, Israel.
Nano X Imaging Ltd management
9- Mr. Erez I. Z. MeltzerCEO & Chairman of the Board · born 1957
- Ms. Tamar Aharon CohenExecutive VP & Chief Marketing Officer · born 1977
- Mr. James M. DaraGM of Source & Services Division and Head of Nanox USA · born 1970
- Ms. Marina Gofman FelerChief Legal Officer · born 1989
- Dr. Ilung Kim Ph.D.Head of Nanox Korea · born 1959
- Ms. Gali Yahav AttiasChief of Corporate Resources · born 1979
- Dr. Lawrence N. Tanenbaum FACR, M.D.Chief Medical Officer of US
- Dr. Michael Yuz M.D., MBAPresident & CMO, USARAD Holdings Inc.
- Ms. Elli YuzCEO OF USARAD Holdings Inc.